1. Home
  2. ELTX vs QH Comparison

ELTX vs QH Comparison

Compare ELTX & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • QH
  • Stock Information
  • Founded
  • ELTX 2011
  • QH 2012
  • Country
  • ELTX United States
  • QH China
  • Employees
  • ELTX N/A
  • QH N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • QH Business Services
  • Sector
  • ELTX Health Care
  • QH Consumer Discretionary
  • Exchange
  • ELTX Nasdaq
  • QH Nasdaq
  • Market Cap
  • ELTX 121.7M
  • QH 104.9M
  • IPO Year
  • ELTX N/A
  • QH 2020
  • Fundamental
  • Price
  • ELTX $8.09
  • QH $1.30
  • Analyst Decision
  • ELTX Strong Buy
  • QH
  • Analyst Count
  • ELTX 2
  • QH 0
  • Target Price
  • ELTX $9.50
  • QH N/A
  • AVG Volume (30 Days)
  • ELTX 46.9K
  • QH 22.2K
  • Earning Date
  • ELTX 08-12-2025
  • QH 08-27-2025
  • Dividend Yield
  • ELTX N/A
  • QH N/A
  • EPS Growth
  • ELTX N/A
  • QH N/A
  • EPS
  • ELTX N/A
  • QH 0.01
  • Revenue
  • ELTX N/A
  • QH $417,431,053.00
  • Revenue This Year
  • ELTX N/A
  • QH N/A
  • Revenue Next Year
  • ELTX N/A
  • QH N/A
  • P/E Ratio
  • ELTX N/A
  • QH $144.82
  • Revenue Growth
  • ELTX N/A
  • QH N/A
  • 52 Week Low
  • ELTX $3.70
  • QH $0.25
  • 52 Week High
  • ELTX $9.99
  • QH $2.27
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 62.14
  • QH 54.65
  • Support Level
  • ELTX $7.76
  • QH $1.16
  • Resistance Level
  • ELTX $8.94
  • QH $1.45
  • Average True Range (ATR)
  • ELTX 0.37
  • QH 0.09
  • MACD
  • ELTX -0.03
  • QH 0.01
  • Stochastic Oscillator
  • ELTX 51.09
  • QH 42.23

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.

Share on Social Networks: